Evidence map›Paper›PMID 38864694›Full record

ArticleJournal of cellular and molecular medicine2024

Whole-exome sequencing for genetic diagnosis of idiopathic liver injury in children.

Aysima Atılgan Lülecioğlu, Yılmaz Yücehan Yazıcı, Alperen Baran, Khaled Warasnhe, Şengül Beyaz, Caner Aytekin, Figen Özçay, Yusuf Aydemir, Zeren Barış, Serkan Belkaya

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aysima Atılgan LülecioğluDepartment of Molecular Biology and Genetics, Faculty of Science, İhsan Doğramacı Bilkent University, Ankara, Turkey.
Yılmaz Yücehan YazıcıDepartment of Molecular Biology and Genetics, Faculty of Science, İhsan Doğramacı Bilkent University, Ankara, Turkey.
Alperen BaranDepartment of Molecular Biology and Genetics, Faculty of Science, İhsan Doğramacı Bilkent University, Ankara, Turkey.
Khaled WarasnheDepartment of Pediatrics, Başkent University Faculty of Medicine, Ankara, Turkey.
Şengül BeyazDepartment of Immunology and Allergy Diseases, Ankara Bilkent City Hospital, Ankara, Turkey.
Caner AytekinDepartment of Pediatric Immunology, Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Ankara, Turkey.
Figen ÖzçayDepartment of Pediatric Gastroenterology and Hepatology, Başkent University Faculty of Medicine, Ankara, Turkey.
Yusuf AydemirDepartment of Pediatric Gastroenterology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
Zeren BarışDepartment of Pediatric Gastroenterology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir, Turkey.
Serkan BelkayaDepartment of Molecular Biology and Genetics, Faculty of Science, İhsan Doğramacı Bilkent University, Ankara, Turkey.ORCID 0000-0003-4214-382X

Funding

European Molecular Biology Organization Installation Grant 4727Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 118C375
6 · The paper itself

Abstract

Genome-wide approaches, such as whole-exome sequencing (WES), are widely used to decipher the genetic mechanisms underlying inter-individual variability in disease susceptibility. We aimed to dissect inborn monogenic determinants of idiopathic liver injury in otherwise healthy children. We thus performed WES for 20 patients presented with paediatric-onset recurrent elevated transaminases (rELT) or acute liver failure (ALF) of unknown aetiology. A stringent variant screening was undertaken on a manually-curated panel of 380 genes predisposing to inherited human diseases with hepatobiliary involvement in the OMIM database. We identified rare nonsynonymous variants in nine genes in six patients (five rELT and one ALF). We next performed a case-level evaluation to assess the causal concordance between the gene mutated and clinical symptoms of the affected patient. A genetic diagnosis was confirmed in four rELT patients (40%), among whom two carried novel mutations in ACOX2 or PYGL, and two had previously-reported morbid variants in ABCB4 or PHKA2. We also detected rare variants with uncertain clinical significance in CDAN1, JAG1, PCK2, SLC27A5 or VPS33B in rELT or ALF patients. In conclusion, implementation of WES improves diagnostic yield and enables precision management in paediatric cases of liver injury with unknown aetiology, in particular recurrent hypertransaminasemia.

Indexed as

Exome SequencingGenetic Predisposition to DiseaseMutationAdolescentChildChild, PreschoolFemaleHumansInfantLiver DiseasesLiver Failure, AcuteMaleTransaminasesTransaminasesacute liver failurechildrenidiopathic hepatic injuryrecurrent elevated transaminaseswhole‐exome sequencing

Identifiers

PMID38864694
PMCPMC11167704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.